WASHINGTON (AP) - A Colorado-based solar panel maker that received a $400 million loan guarantee from the Obama administration said Thursday it will file for bankruptcy, the latest setback for an industry battered by the recession and stiff competition from companies in China.
SAN FRANCISCO (AP) - Google unveiled its attempt to catch up to Apple and Amazon in the growing market for tablet computers. It also provided a titillating glimpse at its vision of a digital future through the mind-boggling lens of Internet-connected glasses.
SAN FRANCISCO (AP) - Web game maker Zynga is trying to turn its digital playground into an even more entertaining place, working to prove wrong investors who doubt that it can build a long-lasting business.
NEW YORK (AP) - Two dozen people on four continents, including alleged two hackers from New York, have been arrested in an elaborate sting targeting a black market for online financial fraud, federal officials said Tuesday.
NEW YORK (AP) - Verizon Wireless on Monday said that it has agreed to sell some wireless spectrum rights to T-Mobile USA and swap others, in a continuing quest to get regulators to approve a bigger spectrum deal it has worked out with a consortium of cable companies and another wireless carrier.
WASHINGTON (AP) - Americans bought new homes in May at the fastest pace in more than two years. The increase suggests a modest recovery is continuing in the U.S. housing market, despite weaker job growth.
WASHINGTON (AP) - Congressional bargainers appeared to be closing in on a compromise that would head off a July 1 doubling of interest rates on federal loans to 7.4 million college students and end an election-year battle between President Barack Obama and Congress.
SAN FRANCISCO (AP) - Did the National Security Agency plant spyware deep in the hard drives of thousands of computers used by foreign governments, banks and other surveillance targets around the world?
WASHINGTON (AP) - The makers of a twice-rejected pill designed to boost sexual desire in women are hoping a yearlong lobbying push by politicians, women's groups and consumer advocates will move their much-debated drug onto the market.